News & Events category:
Commercialisation of Research
Spotlight on the paediatric oncology research team – Childhood Cancer Awareness Month
September marks Childhood Cancer Awareness Month and we are shining a spotlight on the paediatric oncology research team at Royal Manchester Children’s Hospital.
NHS 70 research discoveries: Improving quality of life for children with rare inherited metabolic diseases worldwide since the 1990s
Thousands of children suffering from rare inherited metabolic diseases worldwide have dramatically better life expectancy and quality of life thanks to research at MFT and The University of Manchester
New early-warning device to detect infection in dialysis patients completes successful clinical pilot at MFT
An innovative solution designed to identify infection in dialysis patients has completed a successful pilot clinical investigation at MFT, following a funding award from Health Innovation Manchester.
Gene test for growth hormone deficiency developed
A new test developed by Manchester scientists could revolutionise the way children with growth hormone deficiency are diagnosed.
£18.5m financing announced for Citylabs 2.0 at MFT
A joint venture between MSPL, the leading UK operator of science and technology campuses, and MFT has been awarded an £18m loan for the pioneering Citylabs 2.0 development on Trust campus.
GM Connected Health City: sharing progress & best practice
The Greater Manchester Connected Health City (GM CHC) & Manchester Ecosystem invite you to an event to showcase the progress of the GM CHC, to share best practice & to explore new ways of using data t
Thank you to everyone who supported our research during 2017
We'd like to say a massive thank you to everyone who participated in, delivered or supported research at Manchester University NHS Foundation Trust during 2017.
Dr John Moore, Clinical Director for Intensive Care talks about Innovation Factor
Dr John Moore, Clinical Director for Intensive Care at Manchester Royal Infirmary and Medical Lead for Enhanced Recovery After Surgery + (ERAS+), talks about Innovation Factor.